Biennial mammography optimal screening interval for average risk women

the ONA take:

A comprehensive analysis of digital mammography tests has indicated that biennial (once every two years) screening is preferable for women of age 50 through 74 that have an average risk of developing breast cancer

This screening frequency should offer  a good balance between prudent detection and the risk of false-positive results.

The study findings indicated that biennial screening maintains an average of 81.2% of annual screening benefits with fewer false-positives; whereas annual screening, although it could avert 3 more cancer deaths, would yield approximately 1988 additional false-positive test results.

This study was a collaboration between six modeling research groups that belong to CISNET, the NCI-sponsored Cancer Intervention and Surveillance Modeling Network, coupled with investigators based at the Breast Cancer Surveillance Consortium (BCSC).

The paper's lead author was Jeanne S. Mandelblatt, MD, MPH, of Georgetown Lombardi Comprehensive Cancer Center (CISNET).

The modeling incorporated national data on breast cancer risk, treatment effects, and incidence of breast cancer; and reviewed one- and two-year screening intervals on individuals with varying starting ages. The research also considered digital screening and breast density factors.

Other modeling findings revealed that  biennial screening during the age span of 50-74 would achieve a roughly 25% mortality reduction. Starting the biennial screening at age 40 averts an average of one additional cancer death but also generates an average of 576 additional false-positive tests.

The paper's lead author cautioned that these model findings should still not override a screening frequency determination based on individual factors, based on acceptance of false-positive results, over treatment, etc. She stated that screening frequency must be balanced against the risk of chemotherapy and/or radiation treatment that may not needed.

Biennial mammography optimal screening interval for average risk women
Biennial (once every two years) screening is preferable for women of age 50 through 74 that have an average risk of developing breast cancer.
Results from a second comprehensive analysis of mammography screening confirms findings from a 2009 analysis of film mammography: biennial screening offers a favorable balance of benefits to harm for women ages 50 to 74 who have an average risk of developing breast cancer.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs